Characteristics | Number | Frequency (%) |
---|---|---|
Age (years) | ||
Median (interquartile range) | 39(20-77) | |
<55 | 34 | 83 |
≥55 | 7 | 17 |
Gender | ||
Female | 30 | 73 |
Male | 11 | 27 |
Size Tumor (cm) | ||
Median (range) | 1.2(0.6-3.2) | |
mPTC (≤1) | 18 | 44 |
PTC (>1) | 23 | 56 |
Predominant variant | ||
Classic | 29 | 71 |
Follicular | 7 | 17 |
Othera | 3 | 7 |
Not available | 2 | 5 |
Multicentricity | ||
No | 17 | 41 |
Yes | 24 | 59 |
Extrathyroidal extension | ||
No | 20 | 49 |
Yes | 21 | 51 |
Lymph Nodes involvement | ||
No | 25 | 61 |
Yes | 16 | 39 |
Angiolymphatic invasion | ||
No | 39 | 95 |
Yes | 1 | 5 |
Perineural invasion | ||
No | 36 | 88 |
Yes | 2 | 5 |
Not available | 3 | 7 |
Outcome | ||
Favorableb | 36 | 88 |
Poor c | 5 | 12 |
Follow-up | ||
>5 years | 36 | 88 |
<5 years | 5 | 12 |
Somatic alterations | ||
BRAF mutation | 28 | 68 |
BRAF wild-type | 13 | 32 |
RAS mutation | 0 | 0 |
RAS wild-type | 41 | 100 |
RET/PTC inversion | 5 | 12 |
RET/PTC wild-type | 36 | 88 |